News
All the latest news from Quadratech Diagnostics. If you would like to receive updates via our newsletter then please sign up here.
Showing Category:
New Assays For Measuring Direct Thrombin Inhibitors in Plasma
Direct Thrombin Inhibitors (DTIs) have increasing and promising curative, preventive or prophylactic applications in severe clinical situations. Laboratory methods are required for adjustment of drug efficacy and for avoiding overdosage. Specialized calibrated clotting and chromogenic assays for quantitating various DTIs have been developed and compared for their efficacy. Results show excellent performance with Hirudin and analogues, but were not found to be suitable for the Argatroban® usual therapeutic range.
55th Annual Meeting Society of Thrombosis and Haemostasis Research – [Dabigatran]
Dabigatran calibrator and control plasmas for drug measurement in plasma, when required Amiral J.1, Stangier J.2, Peyrafitte M.1 1HYPHEN BioMed, research, Neuville sur Oise, France. 2Boehringer Ingelheim Pharma Gmbh & Co KG, Biberach an der Riss, Germany
55th Annual Meeting Society of Thrombosis and Haemostasis Research – [PS]
Highly stable and robust protein S clotting assay validated for easier laboratory practice Amiral J.1, Peyrafitte M.2, Vissac A.M.2 1HYPHEN BioMed, Neuville sur Oise, France. 2HYPHEN BioMed, Research, Neuville sur Oise, France
55th Annual Meeting Society of Thrombosis and Haemostasis Research – [Anti-FVIII]
Development of an individual Anti-FVIII Inhibitors ELISA to improve Haemophiliacs therapeutic follow up Peyrafitte M.1, Vissac A.M.1, Amiral J.2 1HYPHEN BioMed, Research, Neuville sur Oise, France. 2HYPHEN BioMed, Neuville sur Oise, France
55th Annual Meeting Society of Thrombosis and Haemostasis Research – [TF]
Microparticles exposing Tissue Factor in human plasma Laroche M.1, Vissac A.M.1, Peyrafitte M.1, Amiral J.2 1HYPHEN BioMed, Research, Neuville sur Oise, France 2HYPHEN BioMed, Neuville sur Oise, France
55th Annual Meeting Society of Thrombosis and Haemostasis Research – [MP-TF]
The multiple faces of tissue factor measured with laboratory assays Laroche M.1, Peyrafitte M.1, Vissac A.M.1, Amiral J.2 1HYPHEN BioMed, Research, Neuville sur Oise, 2HYPHEN BioMed, Neuville sur Oise, France
NEQAS Blood Coagulation Annual Scientific Meeting September 2012
We had our usual space at this annual meeting and managed to sit in on some excellent presentations.
Update on Potential New Anticoagulants – www.pmlive.com
Modern anticoagulants threaten status quo. Could the shift towards first-in-class novel oral treatments, which are expected to prove beneficial for prevention of stroke caused by AF, render warfarin obselete?
London Olympics 2012 Traffic Restrictions and their impact on delivery times
Quadratech are liaising with our couriers ‘Wey Group International’ to minimise the disruption caused by the London 2012 Olympics.
EXHIBITIONS AND MEETINGS FOR 2012
Quadratech will be exhibiting at or attending the following meetings in 2012
EXHIBITIONS AND MEETINGS FOR 2011
2011 is a landmark year for Quadratech as it is our 20th Birthday. The company was founded in 1991 and has continued to grow and thrive over the intervening years, to the company you know today.
MICROPARTICLES MEETING
In September 2010 amongst the dreaming spires of Oxford's Magdalen College the topic of 'Micro and Nanovesicles in Health and Disease' was explored.
